LSTA
Lisata Therapeutics, Inc. - Common Stock (LSTA)
$51
About Lisata Therapeutics, Inc. - Common Stock (LSTA)
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.
Details
Daily high
$2.51
Daily low
$2.40
Price at open
$2.49
52 Week High
$4.20
52 Week Low
$1.87
Market cap
21.8M
Dividend yield
0.00%
Volume
15,162
Avg. volume
14,402
P/E ratio
-1.05
Lisata Therapeutics, Inc. - Common Stock News
Details
Daily high
$2.51
Daily low
$2.40
Price at open
$2.49
52 Week High
$4.20
52 Week Low
$1.87
Market cap
21.8M
Dividend yield
0.00%
Volume
15,162
Avg. volume
14,402
P/E ratio
-1.05